Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Select a radio player from the list below. Audio playback requires significantly more data usage than loading CBC Lite story pages.

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.